Professional Documents
Culture Documents
Recent acquisitions to offset impact of soft P&C pricing, drive long term growth
NYSE BUY Fundamental research indicates a 31% upside in the NYSE common stock over the next 6-12 months.
Direct access to
We have calculated the the
targetfull
pricereport
based onfree of charge
fundamental factors,at
using a weighted average of target
Common prices obtained using DCF and comparative valuation methodologies. We continue to value the
Stock http://www.iirgroup.com/researchoracle/viewreport/show/20296
company over a 6-12 month investment horizon, as the reinsurance industry in which it operates is
highly cyclical and, therefore, trends can be captured more accurately with a shorter investment
horizon.
Ticker: ACE
Target price: US$69.34 We reiterate the NYSE common stock a BUY on fundamental grounds, with a 6-12 month target price
Current price: US$52.86 of US$69.34.
European BUY The European stock is expected to appreciate approximately 37% over the next 6-12 months, as the
31% fundamental upside and 7 percentage points’ further upside, attributable to the anticipated
Stock1 appreciation of the US dollar against the euro over our investment horizon, are partially offset by
approximately 1 percentage point’s downside attributable to the anticipated increase in the European
Ticker: ACEL.F stock discount2.
Target price: €45.71
Current price: €33.40 We reiterate the European stock a BUY, with a 6-12 month target price of €45.71.